Skip to main content
Livermore
Livermore
ZHEN

Advisor Group Holdings, Inc.

SEC CIK
0001677044
Latest filing
Aug 14, 2026

INBX holding history

Inhibrx Biosciences, Inc. in every 13F filed by Advisor Group Holdings, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INBX overviewAll 13F holders of INBXFull Q2 2026 holdings

Shares (Q2 2026)
78
Value
$7.39K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of INBX by Advisor Group Holdings, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202678$7.39K<0.1%+8+11.4%AddedHolders
Q1 202670$4.71K<0.1%+2+2.9%AddedHolders
Q4 202568$5.37K<0.1%−51−42.9%ReducedHolders
Q3 2025119$4.01K<0.1%+35+41.7%AddedHolders
Q2 202584$1.20K<0.1%+84NewHolders
Q1 20250$00.0%−1,751−100.0%Sold outHolders
Q4 20241,751$27.0K<0.1%+1,666+1,960.0%AddedHolders
Q3 202485$1.33K<0.1%−6,685−98.7%ReducedHolders
Q2 20246,770$229.3K<0.1%−457−6.3%ReducedHolders
Q1 20247,227$252.7K<0.1%−388−5.1%ReducedHolders
Q4 20237,615$289.4K<0.1%−7,645−50.1%ReducedHolders
Q3 202315,260$280.0K<0.1%+7,180+88.9%AddedHolders
Q2 20238,080$209.8K<0.1%−285−3.4%ReducedHolders
Q1 20238,365$157.8K<0.1%00.0%UnchangedHolders
Q4 20228,365$206.0K<0.1%−480−5.4%ReducedHolders
Q3 20228,845$159.0K<0.1%−200−2.2%ReducedHolders
Q2 20229,045$102.0K<0.1%−525−5.5%ReducedHolders
Q1 20229,570$213.0K<0.1%+300+3.2%AddedHolders
Q4 20219,270$405.0K<0.1%−1,400−13.1%ReducedHolders
Q3 202110,670$355.0K<0.1%00.0%UnchangedHolders
Q2 202110,670$294.0K<0.1%+6,970+188.4%AddedHolders
Q1 20213,700$74.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.